0001209191-23-044984.txt : 20230808
0001209191-23-044984.hdr.sgml : 20230808
20230808162356
ACCESSION NUMBER: 0001209191-23-044984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230807
FILED AS OF DATE: 20230808
DATE AS OF CHANGE: 20230808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burgess Justin
CENTRAL INDEX KEY: 0001812025
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 231151765
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION
STREET 2: 2100 POWELL STREET, SUITE 1900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-07
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001812025
Burgess Justin
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
0
1
0
0
Chief Accounting Officer
0
Common Stock
2023-08-07
4
M
0
2528
5.42
A
2528
D
Common Stock
2023-08-07
4
M
0
5533
9.41
A
8061
D
Common Stock
2023-08-07
4
S
0
8061
14.545
D
0
D
Stock Option (Right to Buy)
5.42
2023-08-07
4
M
0
2528
D
2027-02-11
Common Stock
2528
0
D
Stock Option (Right to Buy)
9.41
2023-08-07
4
M
0
5533
D
2028-02-02
Common Stock
5533
2767
D
This transaction was executed in multiple trades at prices ranging from $14.54 to $14.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 12. 2020, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Not applicable.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 3, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
/s/ Justin Burgess
2023-08-08